These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1376623)

  • 1. Proliferative responses of a bovine leukemia virus-infected lymphoblastoid B-cell line by its culture supernatant and cytokines.
    Yang MP; Goitsuka R; Tsujimoto H; Hasegawa A
    J Vet Med Sci; 1992 Apr; 54(2):255-9. PubMed ID: 1376623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumor-associated antigen on the proliferation of bovine leukemia virus-infected lymphoblastoid B-cell lines.
    Yang MP; Goitsuka R; Tsujimoto H; Onuma M; Hasegawa A
    J Vet Med Sci; 1992 Aug; 54(4):757-61. PubMed ID: 1327182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
    Chelstrom LM; Finnegan D; Uckun FM
    Leuk Lymphoma; 1992 May; 7(1-2):79-86. PubMed ID: 1282065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of differentiation-inducing factor and other cytokines on induction of differentiation of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M; Maurer HR; Okabe T; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):115-21. PubMed ID: 2470711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O; Gillis S; Kabelitz D
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine-activated effector cells: modulation of activity by cytokines.
    Mehta S; Flanagan P; Blackinton D; Wanebo H
    Lymphokine Cytokine Res; 1992 Apr; 11(2):73-7. PubMed ID: 1581419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
    Makrynikola V; Kabral A; Bradstock KF
    Exp Hematol; 1991 Aug; 19(7):674-9. PubMed ID: 1893954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.